An ECF-type transporter scavenges heme to overcome iron-limitation in Staphylococcus lugdunensis

  1. Angelika Jochim
  2. Lea Adolf
  3. Darya Belikova
  4. Nadine Anna Schilling
  5. Inda Setyawati
  6. Danny Chin
  7. Severien Meyers
  8. Peter Verhamme
  9. David E Heinrichs
  10. Dirk J Slotboom
  11. Simon Heilbronner  Is a corresponding author
  1. University of Tübingen, Germany
  2. University of Groningen, Netherlands
  3. University of Western Ontarion, Canada
  4. KU Leuven, Belgium
  5. University of Western Ontario, Canada

Abstract

Energy-coupling factor type (ECF-transporters) represent trace nutrient acquisition systems. Substrate binding components of ECF-transporters are membrane proteins with extraordinary affinity, allowing them to scavenge trace amounts of ligand. A number of molecules have been described as substrates of ECF-transporters, but an involvement in iron-acquisition is unknown. Host-induced iron limitation during infection represents an effective mechanism to limit bacterial proliferation. We identified the iron-regulated ECF-transporter Lha in the opportunistic bacterial pathogen Staphylococcus lugdunensis and show that the transporter is specific for heme. The recombinant substrate-specific subunit LhaS accepted heme from diverse host-derived hemoproteins. Using isogenic mutants and recombinant expression of Lha, we demonstrate that its function is independent of the canonical heme acquisition system Isd and allows proliferation on human cells as sources of nutrient iron. Our findings reveal a unique strategy of nutritional heme acquisition and provide the first example of an ECF-transporter involved in overcoming host-induced nutritional limitation.

Data availability

The datasets gained during the current study are available at Dryad Digital Repository under the doi:10.5061/dryad.fqz612jqc

The following data sets were generated

Article and author information

Author details

  1. Angelika Jochim

    Department of Infection Biology, University of Tübingen, Tübingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Lea Adolf

    Department of Infection Biology, University of Tübingen, Tübingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Darya Belikova

    Department of Infection Biology, University of Tübingen, Tübingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Nadine Anna Schilling

    Institute of Organic Chemistry, University of Tübingen, Tübingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Inda Setyawati

    Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  6. Danny Chin

    Department of Microbiology and Immunology, University of Western Ontarion, London, Canada
    Competing interests
    The authors declare that no competing interests exist.
  7. Severien Meyers

    Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3481-4793
  8. Peter Verhamme

    Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  9. David E Heinrichs

    Department of Microbiology and Immunology, University of Western Ontario, London, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7217-2456
  10. Dirk J Slotboom

    Groningen Biomolecular and Biotechnology Institute (GBB), University of Groningen, Groningen, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5804-9689
  11. Simon Heilbronner

    Department of Infection Biology, University of Tübingen, Tübingen, Germany
    For correspondence
    simon.heilbronner@uni-tuebingen.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6774-2311

Funding

Deutsche Forschungsgemeinschaft (HE8381/3-1)

  • Simon Heilbronner

Deutsche Forschungsgemeinschaft (EXC2124)

  • Simon Heilbronner

Nederlandse Organisatie voor Wetenschappelijk Onderzoek (TOP grant 714.018.003)

  • Dirk J Slotboom

Canadian Institutes of Health Research (PJT-153308)

  • David E Heinrichs

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Animal experiments were performed in strict accordance with the European Health Law of the Federation of Laboratory Animal Science Associations. The protocol was approved by the Regierungspräsidium Tübingen (IMIT1/17)

Human subjects: Human Erythrocytes were isolated from venous blood of healthy volunteers in accordance with protocols approved by the Institutional Review Board for Human Subjects at the University of Tübingen. Informed written consent was obtained from all volunteers.

Copyright

© 2020, Jochim et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,973
    views
  • 234
    downloads
  • 20
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Angelika Jochim
  2. Lea Adolf
  3. Darya Belikova
  4. Nadine Anna Schilling
  5. Inda Setyawati
  6. Danny Chin
  7. Severien Meyers
  8. Peter Verhamme
  9. David E Heinrichs
  10. Dirk J Slotboom
  11. Simon Heilbronner
(2020)
An ECF-type transporter scavenges heme to overcome iron-limitation in Staphylococcus lugdunensis
eLife 9:e57322.
https://doi.org/10.7554/eLife.57322

Share this article

https://doi.org/10.7554/eLife.57322

Further reading

    1. Microbiology and Infectious Disease
    Li Zhang, Fen Hu ... Hang Yang
    Research Article

    Phage-derived peptidoglycan hydrolases (i.e. lysins) are considered promising alternatives to conventional antibiotics due to their direct peptidoglycan degradation activity and low risk of resistance development. The discovery of these enzymes is often hampered by the limited availability of phage genomes. Herein, we report a new strategy to mine active peptidoglycan hydrolases from bacterial proteomes by lysin-derived antimicrobial peptide-primed screening. As a proof-of-concept, five peptidoglycan hydrolases from the Acinetobacter baumannii proteome (PHAb7-PHAb11) were identified using PlyF307 lysin-derived peptide as a template. Among them, PHAb10 and PHAb11 showed potent bactericidal activity against multiple pathogens even after treatment at 100°C for 1 hr, while the other three were thermosensitive. We solved the crystal structures of PHAb8, PHAb10, and PHAb11 and unveiled that hyper-thermostable PHAb10 underwent a unique folding-refolding thermodynamic scheme mediated by a dimer-monomer transition, while thermosensitive PHAb8 formed a monomer. Two mouse models of bacterial infection further demonstrated the safety and efficacy of PHAb10. In conclusion, our antimicrobial peptide-primed strategy provides new clues for the discovery of promising antimicrobial drugs.

    1. Ecology
    2. Microbiology and Infectious Disease
    Tom Clegg, Samraat Pawar
    Research Article Updated

    Predicting how species diversity changes along environmental gradients is an enduring problem in ecology. In microbes, current theories tend to invoke energy availability and enzyme kinetics as the main drivers of temperature-richness relationships. Here, we derive a general empirically-grounded theory that can explain this phenomenon by linking microbial species richness in competitive communities to variation in the temperature-dependence of their interaction and growth rates. Specifically, the shape of the microbial community temperature-richness relationship depends on how rapidly the strength of effective competition between species pairs changes with temperature relative to the variance of their growth rates. Furthermore, it predicts that a thermal specialist-generalist tradeoff in growth rates alters coexistence by shifting this balance, causing richness to peak at relatively higher temperatures. Finally, we show that the observed patterns of variation in thermal performance curves of metabolic traits across extant bacterial taxa is indeed sufficient to generate the variety of community-level temperature-richness responses observed in the real world. Our results provide a new and general mechanism that can help explain temperature-diversity gradients in microbial communities, and provide a quantitative framework for interlinking variation in the thermal physiology of microbial species to their community-level diversity.